Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 391

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 391
---
 issuance of shares of the Company’s common stock with an estimated fair value of $19.3million (the “Acquisition”). The Company considers completion of the merger agreement to be probable. The accompanying unaudited pro forma condensed combined statement of financial position as at December 31, 2024 gives effect to the Acquisition as if it had been consummated on December 31, 2024; and the accompanying unaudited pro forma condensed combined statement of operations for the year ended December 31, 2024 gives effect to the Acquisition as if it had been consummated on January 1, 2024. The following unaudited pro forma condensed combined balance sheet as of December 31,2024, combines the historical consolidated balance sheet of Aptorum as of December 31, 2024 with the historical balance sheet of DiamiR as of February 28, 2025 giving further effect to the pro forma adjustments described in Note (i) to the “ Notes To The Unaudited Pro Forma Consolidated Combined Financial Information”included in this proxy statement/prospectus, as if they had been consummated as of December 31, 2024. The following unaudited pro forma consolidated combined statements of operations for the year ended December 31, 2024 combine the historical consolidated statement of operations of Aptorum for the year ended December 31, 2024 and the historical statements of operations of DiamiR for the twelve months ended February 28, 2025 (consisting of the first nine months of its fiscal year ending May 31, 2025 and the last three months of its fiscal year ended May 31, 2024, giving effect to the pro forma adjustments described in Note (i) to the “ Notes To The Unaudited Pro Forma Consolidated Combined Financial Information” included in this proxy statement/prospectus, as if they had been consummated on January 1, 2024, the beginning of the earliest period presented. The unaudited pro forma consolidated combined financial statements have been derived from and should be read in connection with: •the accompanying notes to the unaudited pro forma consolidated combined financial statements; •the historical unaudited financial statements of DiamiR as of and for the nine months ended February28, 2025 and the related notes included in this proxy statement/prospectus; •the historical audited consolidated financial statements of Aptorum as of and for the year ended December31, 202